Submitted by Anonymous (not verified) on 16 March 2026 - 8:41
Opinion/decision on a Paediatric investigation plan (PIP): Vidaza, azacitidine, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Haematology-Hemostaseology, PIP number: P/0217/2015
Source: